Physician profile
Erika Mathis
NPI 1326681487
$468.32
in general payments reported to CMS, 2019-2025
10 companies · $97.25 in 2025
The $97.25 reported for 2025 was more than what a typical Advanced Practice Midwife provider received nationally (typical 2025 total: $70.87).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $32.05 · 2022: $58.65 · 2023: $66.32 · 2024: $214 · 2025: $97.25.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $378.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $377.62 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Daiichi Sankyo INC. | $103.98 | 2023-2024 | Injectafer |
| Organon LLC | $92.74 | 2022-2025 | Nexplanon |
| Shield Therapeutics INC | $90.79 | 2024-2025 | |
| Sage Therapeutics, LLC | $64.77 | 2021-2025 | Zurzuvae |
| Mayne Pharma Commercial LLC | $29.08 | 2023 | |
| Minerva Surgical, INC | $22.51 | 2022 | |
| Becton, Dickinson and Company | $17.17 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $16.51 | 2022 | |
| Evofem Biosciences, INC. | $16.26 | 2025 | Phexxi, Solosec, Phexx |
| Abbvie INC. | $14.51 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Erika Mathis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.